EOC Pharma, a Chinese biotech developer focused on cancer treatments, has closed a RMB500 million ($71 million) Series C round raised from a group of local private equity investors.
TF Capital, Yingke Private Equity, Hanne Capital, and Everest Venture Capital joined the round, according to a statement, as did clinical trials specialist Tigermed. It follows a $32 million Series B in...
Ucommune, China’s largest co-working space player which is considered the local equivalent to troubled US operator WeWork, has filed for a US IPO.
Chinese drone manufacturer EHang traded flat on its NASDAQ debut following a $40 million IPO that priced at the bottom end of the indicative range.
Tiger Global Management has led a $26 million Series B round for Indian B2B financing platform provider KredX.
New Zealand’s Impact Enterprise Fund (IEF) has confirmed an investment in local sustainable packaging supplier Grounded.